Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia

被引:67
作者
Braus, DF [1 ]
Ende, G [1 ]
Weber-Fahr, W [1 ]
Demirakca, T [1 ]
Tost, H [1 ]
Henn, FA [1 ]
机构
[1] Cent Inst Mental Hlth, NMR Res & Clin Psychiat & Psychotherapy, D-68159 Mannheim, Germany
关键词
cingulate gyrus; schizophrenia; spectroscopic imaging; neuropsychology; neuronal viability; WCST;
D O I
10.1016/S0924-977X(02)00003-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Magnetic resonance spectroscopic imaging provides a non-invasive approach for testing the hypothesis that neuronal function can improve under atypical antipsychotic medication leading to improvement in cognitive function. We studied two groups of schizophrenic patients, one treated exclusively with typical neuroleptics, the other with atypical medications, H-1 MR-spectroscopic imaging of the anterior cingulate gyrus was performed in all patients. Perseveration errors in the Wisconsin Card Sorting Test (WCST) served as an additional marker for cingulate gyrus function, Our results showed that N-acetylaspartate (NAA), a measure of neuronal function, was closely cot-related with perseveration errors seen on the WCST. Patients treated with atypical medications had fewer errors on the WCST and higher NAA levels than those on typical medications. and there was a correlation between the time treated with atypical medication, higher NAA levels and better test performance. These results suggest that atypical antipsychotics modify the function of anterior cingulate neurons in a specific manner. (C) 2002 Published by Elsevier Science B.V./ECNP.
引用
收藏
页码:145 / 152
页数:8
相关论文
共 58 条
[1]  
BENES FM, 1991, ARCH GEN PSYCHIAT, V48, P996
[2]   PHYSIOLOGICAL ACTIVATION OF A CORTICAL NETWORK DURING PERFORMANCE OF THE WISCONSIN CARD SORTING TEST - A POSITRON EMISSION TOMOGRAPHY STUDY [J].
BERMAN, KF ;
OSTREM, JL ;
RANDOLPH, C ;
GOLD, J ;
GOLDBERG, TE ;
COPPOLA, R ;
CARSON, RE ;
HERSCOVITCH, P ;
WEINBERGER, DR .
NEUROPSYCHOLOGIA, 1995, 33 (08) :1027-1046
[3]   The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia [J].
Bertolino, A ;
Knable, MB ;
Saunders, RC ;
Callicott, JH ;
Kolachana, B ;
Mattay, VS ;
Bachevalier, J ;
Frank, JA ;
Egan, M ;
Weinberger, DR .
BIOLOGICAL PSYCHIATRY, 1999, 45 (06) :660-667
[4]   The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia [J].
Bertolino, A ;
Callicott, JH ;
Mattay, VS ;
Weidenhammer, KM ;
Rakow, R ;
Egan, MF ;
Weinberger, DR .
BIOLOGICAL PSYCHIATRY, 2001, 49 (01) :39-46
[5]   Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia [J].
Bertolino, A ;
Esposito, G ;
Callicott, JH ;
Mattay, VS ;
Van Horn, JD ;
Frank, JA ;
Berman, KF ;
Weinberger, DR .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (01) :26-33
[6]  
Bertolino A, 1998, NEUROPSYCHOPHARMACOL, V18, P1
[7]  
Bleuler E., 1950, DEMENTIA PRAECOX GRO
[8]   WISCONSIN CARD SORTING TEST DEFICITS IN CHRONIC PARANOID SCHIZOPHRENIA - EVIDENCE FOR A RELATIVELY DISCRETE SUBGROUP [J].
BUTLER, RW ;
JENKINS, MA ;
SPROCK, J ;
BRAFF, DL .
SCHIZOPHRENIA RESEARCH, 1992, 7 (02) :169-176
[9]   Radioreceptor binding profile of the atypical antipsychotic olanzapine [J].
Bymaster, FP ;
Calligaro, DO ;
Falcone, JF ;
Marsh, RD ;
Moore, NA ;
Tye, NC ;
Seeman, P ;
Wong, DT .
NEUROPSYCHOPHARMACOLOGY, 1996, 14 (02) :87-96
[10]   Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications [J].
Carlsson, A ;
Hansson, LO ;
Waters, N ;
Carlsson, ML .
LIFE SCIENCES, 1997, 61 (02) :75-94